Home > Publications database > Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. > print

001     282340
005     20240229155038.0
024 7 _ |a 10.1038/s41588-023-01466-z
|2 doi
024 7 _ |a pmid:37592023
|2 pmid
024 7 _ |a 1061-4036
|2 ISSN
024 7 _ |a 1546-1718
|2 ISSN
024 7 _ |a altmetric:153030529
|2 altmetric
037 _ _ |a DKFZ-2023-01724
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Wilcox, Naomi
|b 0
245 _ _ |a Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
260 _ _ |a London
|c 2023
|b Macmillan Publishers Limited, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1694685378_9617
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Sep;55(9):1435-1439
520 _ _ |a Linkage and candidate gene studies have identified several breast cancer susceptibility genes, but the overall contribution of coding variation to breast cancer is unclear. To evaluate the role of rare coding variants more comprehensively, we performed a meta-analysis across three large whole-exome sequencing datasets, containing 26,368 female cases and 217,673 female controls. Burden tests were performed for protein-truncating and rare missense variants in 15,616 and 18,601 genes, respectively. Associations between protein-truncating variants and breast cancer were identified for the following six genes at exome-wide significance (P < 2.5 × 10-6): the five known susceptibility genes ATM, BRCA1, BRCA2, CHEK2 and PALB2, together with MAP3K1. Associations were also observed for LZTR1, ATR and BARD1 with P < 1 × 10-4. Associations between predicted deleterious rare missense or protein-truncating variants and breast cancer were additionally identified for CDKN2A at exome-wide significance. The overall contribution of coding variants in genes beyond the previously known genes is estimated to be small.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Dumont, Martine
|b 1
700 1 _ |a González-Neira, Anna
|b 2
700 1 _ |a Carvalho, Sara
|b 3
700 1 _ |a Joly Beauparlant, Charles
|b 4
700 1 _ |a Crotti, Marco
|b 5
700 1 _ |a Luccarini, Craig
|b 6
700 1 _ |a Soucy, Penny
|b 7
700 1 _ |a Dubois, Stéphane
|b 8
700 1 _ |a Nuñez-Torres, Rocio
|b 9
700 1 _ |a Pita, Guillermo
|b 10
700 1 _ |a Gardner, Eugene J
|0 0000-0001-9671-1533
|b 11
700 1 _ |a Dennis, Joe
|b 12
700 1 _ |a Alonso, M Rosario
|b 13
700 1 _ |a Álvarez, Nuria
|b 14
700 1 _ |a Baynes, Caroline
|b 15
700 1 _ |a Collin-Deschesnes, Annie Claude
|b 16
700 1 _ |a Desjardins, Sylvie
|b 17
700 1 _ |a Becher, Heiko
|0 0000-0002-8808-6667
|b 18
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 19
|u dkfz
700 1 _ |a Bolla, Manjeet K
|b 20
700 1 _ |a Castelao, Jose E
|b 21
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 22
|u dkfz
700 1 _ |a Cornelissen, Sten
|b 23
700 1 _ |a Dörk, Thilo
|0 0000-0002-9458-0282
|b 24
700 1 _ |a Engel, Christoph
|b 25
700 1 _ |a Gago-Dominguez, Manuela
|b 26
700 1 _ |a Guénel, Pascal
|0 0000-0002-8359-518X
|b 27
700 1 _ |a Hadjisavvas, Andreas
|b 28
700 1 _ |a Hahnen, Eric
|b 29
700 1 _ |a Hartman, Mikael
|b 30
700 1 _ |a Herráez, Belén
|b 31
700 1 _ |a Investigators, SGBCC
|b 32
|e Collaboration Author
700 1 _ |a Jung, Audrey Ying-Chee
|0 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
|b 33
700 1 _ |a Keeman, Renske
|b 34
700 1 _ |a Kiechle, Marion
|b 35
700 1 _ |a Li, Jingmei
|0 0000-0001-8587-7511
|b 36
700 1 _ |a Loizidou, Maria A
|b 37
700 1 _ |a Lush, Michael
|0 0000-0001-5945-3440
|b 38
700 1 _ |a Michailidou, Kyriaki
|0 0000-0001-7065-1237
|b 39
700 1 _ |a Panayiotidis, Mihalis I
|0 0000-0002-1450-3552
|b 40
700 1 _ |a Sim, Xueling
|0 0000-0002-1233-7642
|b 41
700 1 _ |a Teo, Soo Hwang
|0 0000-0002-0444-590X
|b 42
700 1 _ |a Tyrer, Jonathan P
|0 0000-0003-3724-4757
|b 43
700 1 _ |a van der Kolk, Lizet E
|b 44
700 1 _ |a Wahlström, Cecilia
|b 45
700 1 _ |a Wang, Qin
|b 46
700 1 _ |a Perry, John R B
|0 0000-0001-6483-3771
|b 47
700 1 _ |a Benitez, Javier
|b 48
700 1 _ |a Schmidt, Marjanka K
|0 0000-0002-2228-429X
|b 49
700 1 _ |a Schmutzler, Rita K
|b 50
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 51
700 1 _ |a Droit, Arnaud
|b 52
700 1 _ |a Dunning, Alison M
|0 0000-0001-6651-7166
|b 53
700 1 _ |a Kvist, Anders
|0 0000-0002-1358-0695
|b 54
700 1 _ |a Devilee, Peter
|0 0000-0002-8023-2009
|b 55
700 1 _ |a Easton, Douglas F
|0 0000-0003-2444-3247
|b 56
700 1 _ |a Simard, Jacques
|0 0000-0001-6906-3390
|b 57
700 1 _ |a Tan, Benita Kiat-Tee
|b 58
|e Contributor
700 1 _ |a Tan, Veronique Kiak Mien
|b 59
|e Contributor
700 1 _ |a Tan, Su-Ming
|b 60
|e Contributor
700 1 _ |a Lim, Geok Hoon
|b 61
|e Contributor
700 1 _ |a Tan, Ern Yu
|b 62
|e Contributor
700 1 _ |a Ho, Peh Joo
|b 63
|e Contributor
700 1 _ |a Khng, Alexis Jiaying
|b 64
|e Contributor
773 _ _ |a 10.1038/s41588-023-01466-z
|0 PERI:(DE-600)1494946-5
|n 9
|p 1435-1439
|t Nature genetics
|v 55
|y 2023
|x 1061-4036
909 C O |p VDB
|o oai:inrepo02.dkfz.de:282340
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-09
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT GENET : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-25
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT GENET : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21